tetradecanoylphorbol acetate has been researched along with Anti-Phospholipid Antibody Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergamini, C; Buggiani, A; Caldini, A; Emmi, L; Fanelli, A; Rapi, S | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Analysis of activation markers CD62 and CD63 after "in vitro" stimulation of platelets in antiphospholipid syndrome patients.
Topics: Antigens, CD; Antiphospholipid Syndrome; Blood Platelets; Humans; Platelet Activation; Platelet Membrane Glycoproteins; Tetradecanoylphorbol Acetate; Tetraspanin 30 | 1997 |